Legal - STAT

Pharma By Madlen Davies, Ivan Ruiz, Jill Langlois, and Rosa Furneaux — The Bureau of Investigative Journalism

‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries

Pharmalot By Ed Silverman

Bristol Myers and Sanofi ordered to pay $834 million to Hawaii for withholding Plavix label

Pharmalot By Ed Silverman

Drug maker agrees to plead guilty to hiding and destroying records before FDA inspection

Pharmalot By Ed Silverman

To the delight of generic drug makers, federal appeals court tosses controversial ‘skinny labeling’ decision

Pharmalot By Ed Silverman

FTC sues drug makers over allegedly illegal deal over an opioid painkiller

Exclusive By Rachel Cohrs

PhRMA sues to block Trump administration 340B rule

Pharma By Ed Silverman

Drug makers sue HHS over a discount program serving low-income populations

Pharmalot By Ed Silverman

Former Merck employee arrested for stealing trade secrets on cancer research

First Opinion By Samuel Tarry and Davis Walsh

Keep Covid-19 vaccination decisions out of the courtroom

Politics By Nicholas Florko

Middlemen sue to block a signature Trump drug pricing proposal

Pharmalot By Ed Silverman

Generic drug makers fear a ‘skinny labeling’ court ruling will pose a huge threat

First Opinion By Gregory Jasani and James Maloy

Emergency department physicians should have the right to due process protection. Many don’t

Pharmalot By Ed Silverman

A historian was cited to support making Purdue a public benefit company. He actually thinks it’s a bad idea

First Opinion By Cecile Riboud

In biopharma mergers and acquisitions, managing regulatory compliance early protects return on investment

Pharmalot By Ed Silverman

Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers

Pharmalot By Ed Silverman

Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue

Pharmalot By Ed Silverman

Abbott sues a former executive for allegedly planning to take Covid-19 diagnostics secrets to a rival

Pharmalot By Ed Silverman

Purdue will plead guilty to federal charges, reaches $8.3 billion deal over opioid crisis

Pharmalot By Ed Silverman

Pharma contributed to attorneys general who want to repeal the Affordable Care Act

Pharmalot By Ed Silverman

State treasurers urge Cardinal Health shareholders to reject CEO bonus over opioid crisis

First Opinion By Joy Sturm

Navigating the new ‘buy American’ drug landscape: opportunities for some, pitfalls for others

Pharmalot By Ed Silverman

AstraZeneca loses first-of-its-kind lawsuit filed by Dutch insurer over patent maneuver

Health Tech By Rebecca Robbins

Teladoc sues Amwell over alleged patent infringement

Pharmalot By Ed Silverman

Supreme Court to review contentious state law governing pharmacy benefit managers

Pharmalot By Ed Silverman

Most Read

McKinsey agrees to $573 million settlement over advice given Purdue and other opioid makers

‘Use that money wisely’: Coalition urges governments to spend opioid settlement funds on evidence-based efforts

Biden administration pumps brakes on signature Trump drug pricing proposal

The history of OxyContin, told through unsealed Purdue documents

The surgeon general and his brother: A family’s painful reckoning with addiction

Surgery that launched Ben Carson’s fame ended poorly for twins

To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose

Patient advocates and scientists launch push to lift ban on ‘three-parent IVF’

All Coverage

‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries

Bristol Myers and Sanofi ordered to pay $834 million to Hawaii for withholding Plavix label

Drug maker agrees to plead guilty to hiding and destroying records before FDA inspection

To the delight of generic drug makers, federal appeals court tosses controversial ‘skinny labeling’ decision

FTC sues drug makers over allegedly illegal deal over an opioid painkiller

PhRMA sues to block Trump administration 340B rule

Drug makers sue HHS over a discount program serving low-income populations

Former Merck employee arrested for stealing trade secrets on cancer research

Keep Covid-19 vaccination decisions out of the courtroom

Middlemen sue to block a signature Trump drug pricing proposal

Generic drug makers fear a ‘skinny labeling’ court ruling will pose a huge threat

Emergency department physicians should have the right to due process protection. Many don’t

A historian was cited to support making Purdue a public benefit company. He actually thinks it’s a bad idea

In biopharma mergers and acquisitions, managing regulatory compliance early protects return on investment

Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers

Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue

Abbott sues a former executive for allegedly planning to take Covid-19 diagnostics secrets to a rival

Purdue will plead guilty to federal charges, reaches $8.3 billion deal over opioid crisis

Pharma contributed to attorneys general who want to repeal the Affordable Care Act

State treasurers urge Cardinal Health shareholders to reject CEO bonus over opioid crisis

Navigating the new ‘buy American’ drug landscape: opportunities for some, pitfalls for others

AstraZeneca loses first-of-its-kind lawsuit filed by Dutch insurer over patent maneuver

Teladoc sues Amwell over alleged patent infringement

Supreme Court to review contentious state law governing pharmacy benefit managers

Appeals court hands FTC a setback that invalidates its ability to claw back millions from AbbVie